: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Flying Publisher

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Prostate Cancer

Free Subscription

Articles published in Int J Radiat Oncol Biol Phys
Retrieve available abstracts of 326 articles:
HTML format
Text format

Single Articles

July 2018

SPRATT DE
Ki-67 Remains Solely a Prognostic Biomarker in Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2018;101:513-515.
PubMed Text format

April 2018

GOMEZ-ITURRIAGA A, Casquero F, Pijoan JI, Crook J, et al
Pretreatment Multiparametric Magnetic Resonance Imaging Findings Are More Accurate Independent Predictors of Outcome Than Clinical Variables in Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2018 Apr 22. pii: S0360-3016(18)30696.
PubMed Text format Abstract available

BRYANT AK, Kader AK, McKay RR, Einck JP, et al
Definitive Radiation Therapy and Survival in Clinically Node-Positive Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2018 Apr 17. pii: S0360-3016(18)30680.
PubMed Text format Abstract available

WILSON JM, Dearnaley DP, Syndikus I, Khoo V, et al
The Efficacy and Safety of Conventional and Hypofractionated High-Dose Radiation Therapy for Prostate Cancer in an Elderly Population: A Subgroup Analysis of the CHHiP Trial.
Int J Radiat Oncol Biol Phys. 2018;100:1179-1189.
PubMed Text format Abstract available

THARMALINGAM H, Choudhury A
Relapsing Prostate Cancer: Castrate or Cure?
Int J Radiat Oncol Biol Phys. 2018;100:1095-1096.
PubMed Text format

March 2018

BRENNER DJ, Hall EJ
Are We Now Able to Define Guidelines for Moderate Hypofractionation in Prostate Cancer Radiation Therapy?
Int J Radiat Oncol Biol Phys. 2018;100:871-873.
PubMed Text format

FONTEYNE V, Sarrazyn C, Swimberghe M, De Meerleer G, et al
4 Weeks Versus 5 Weeks of Hypofractionated High-dose Radiation Therapy as Primary Therapy for Prostate Cancer: Interim Safety Analysis of a Randomized Phase 3 Trial.
Int J Radiat Oncol Biol Phys. 2018;100:866-870.
PubMed Text format Abstract available

VOGELIUS IR, Bentzen SM
Dose Response and Fractionation Sensitivity of Prostate Cancer After External Beam Radiation Therapy: A Meta-analysis of Randomized Trials.
Int J Radiat Oncol Biol Phys. 2018;100:858-865.
PubMed Text format Abstract available

SANDLER HM
Role of Overall Treatment Time in the Management of Prostate Cancer Patients: How to Manage Unscheduled Treatment Interruptions.
Int J Radiat Oncol Biol Phys. 2018;100:841-842.
PubMed Text format

MAINTA IC, Zilli T, Tille JC, De Perrot T, et al
The Effect of Neoadjuvant Androgen Deprivation Therapy on Tumor Hypoxia in High-Grade Prostate Cancer: An (18)F-MISO PET-MRI Study.
Int J Radiat Oncol Biol Phys. 2018 Mar 8. pii: S0360-3016(18)30476.
PubMed Text format Abstract available

VALICENTI RK, Pugh SL, Trabulsi EJ, Sartor O, et al
First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical Prostatectomy.
Int J Radiat Oncol Biol Phys. 2018;100:695-701.
PubMed Text format Abstract available

February 2018

CYSOUW M, Bouman-Wammes E, Hoekstra O, van den Eertwegh A, et al
Prognostic Value of [(18)F]-Fluoromethylcholine Positron Emission Tomography/Computed Tomography Before Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2018 Feb 13. pii: S0360-3016(18)30252.
PubMed Text format Abstract available

TANDBERG DJ, Oyekunle T, Lee WR, Wu Y, et al
Postoperative Radiation Therapy for Prostate Cancer: Comparison of Conventional Versus Hypofractionated Radiation Regimens.
Int J Radiat Oncol Biol Phys. 2018 Feb 8. pii: S0360-3016(18)30248.
PubMed Text format Abstract available

KEALL PJ, Colvill E, O'Brien R, Caillet V, et al
Electromagnetic-Guided MLC Tracking Radiation Therapy for Prostate Cancer Patients: Prospective Clinical Trial Results.
Int J Radiat Oncol Biol Phys. 2018 Feb 6. pii: S0360-3016(18)30222.
PubMed Text format Abstract available

AKSNESSAETHER BY, Solberg A, Klepp OH, Myklebust TA, et al
Does Prophylactic Radiation Therapy to Avoid Gynecomastia in Patients With Prostate Cancer Increase the Risk of Breast Cancer?
Int J Radiat Oncol Biol Phys. 2018 Feb 5. pii: S0360-3016(18)30220.
PubMed Text format Abstract available

WILKINS AC, Gusterson B, Szijgyarto Z, Haviland J, et al
Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2018 Feb 3. pii: S0360-3016(18)30186.
PubMed Text format Abstract available

GRAFF P, Portalez D, Lusque A, Brun T, et al
IDEAL 2a Phase II Study of Ultrafocal Brachytherapy for Low- and Intermediate-risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2018 Feb 2. pii: S0360-3016(18)30180.
PubMed Text format Abstract available

DORTH JA, Lee WR, Chino J, Abouassaly R, et al
Cost-Effectiveness of Primary Radiation Therapy Versus Radical Prostatectomy for Intermediate- to High-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2018;100:383-390.
PubMed Text format Abstract available

January 2018

DESS RT, Devasia TP, Aghdam N, Jackson WC, et al
Patient-Reported Sexual Aid Utilization and Efficacy After Radiation Therapy for Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2018 Jan 31. pii: S0360-3016(18)30127.
PubMed Text format Abstract available

YANG DD, Muralidhar V, Mahal BA, Nguyen PL, et al
Lack of Apparent Survival Benefit With Use of Androgen Deprivation Therapy in Patients With High-risk Prostate Cancer Receiving Combined External Beam Radiation Therapy and Brachytherapy.
Int J Radiat Oncol Biol Phys. 2018;100:53-58.
PubMed Text format Abstract available

ROMESSER PB, Pei X, Shi W, Zhang Z, et al
Prostate-Specific Antigen (PSA) Bounce After Dose-Escalated External Beam Radiation Therapy Is an Independent Predictor of PSA Recurrence, Metastasis, and Survival in Prostate Adenocarcinoma Patients.
Int J Radiat Oncol Biol Phys. 2018;100:59-67.
PubMed Text format Abstract available

JOHNSTONE E, Wyatt JJ, Henry AM, Short SC, et al
Systematic Review of Synthetic Computed Tomography Generation Methodologies for Use in Magnetic Resonance Imaging-Only Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2018;100:199-217.
PubMed Text format Abstract available

QIN N, Shen C, Tsai MY, Pinto M, et al
Full Monte Carlo-Based Biologic Treatment Plan Optimization System for Intensity Modulated Carbon Ion Therapy on Graphics Processing Unit.
Int J Radiat Oncol Biol Phys. 2018;100:235-243.
PubMed Text format Abstract available

CHI MS, Yang KL, Chang YC, Ko HL, et al
Comparing the Effectiveness of Combined External Beam Radiation and Hyperthermia Versus External Beam Radiation Alone in Treating Patients With Painful Bony Metastases: A Phase 3 Prospective, Randomized, Controlled Trial.
Int J Radiat Oncol Biol Phys. 2018;100:78-87.
PubMed Text format Abstract available

December 2017

VIGNEAULT E, Martell K, Taussky D, Husain S, et al
Does Seed Migration Increase the Risk of Second Malignancies in Prostate Cancer Patients Treated With Iodine-125 Loose Seeds Brachytherapy?
Int J Radiat Oncol Biol Phys. 2017 Dec 28. pii: S0360-3016(17)34499.
PubMed Text format Abstract available

MCCLELLAND S 3RD, Jaboin JJ, Mitin T
Is Advocacy for Active Surveillance Over Definitive Intervention in Low-Risk Prostate Cancer Applicable to African American Patients?
Int J Radiat Oncol Biol Phys. 2017;99:1076-1077.
PubMed Text format

WORTEL RC, Heemsbergen WD, Smeenk RJ, Witte MG, et al
Local Protocol Variations for Image Guided Radiation Therapy in the Multicenter Dutch Hypofractionation (HYPRO) Trial: Impact of Rectal Balloon and MRI Delineation on Anorectal Dose and Gastrointestinal Toxicity Levels.
Int J Radiat Oncol Biol Phys. 2017;99:1243-1252.
PubMed Text format Abstract available

WADDLE MR, Sio TT, Van Houten HK, Foote RL, et al
Photon and Proton Radiation Therapy Utilization in a Population of More Than 100 Million Commercially Insured Patients.
Int J Radiat Oncol Biol Phys. 2017;99:1078-1082.
PubMed Text format Abstract available

November 2017

YANG DD, Muralidhar V, Nguyen PL, Buzurovic I, et al
Lack of Benefit From the Addition of External Beam Radiation Therapy to Brachytherapy for Intermediate- and High-risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2017;99:904-911.
PubMed Text format Abstract available

KOONTZ BF
Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer: The Hunt for the Silver Bullet.
Int J Radiat Oncol Biol Phys. 2017;99:761-763.
PubMed Text format

VAN DER VELDEN JM, Peters M, Verlaan JJ, Versteeg AL, et al
Development and Internal Validation of a Clinical Risk Score to Predict Pain Response After Palliative Radiation Therapy in Patients With Bone Metastases.
Int J Radiat Oncol Biol Phys. 2017;99:859-866.
PubMed Text format Abstract available

LIM-REINDERS S, Keller BM, Al-Ward S, Sahgal A, et al
Online Adaptive Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2017;99:994-1003.
PubMed Text format Abstract available

BARADARAN-GHAHFAROKHI M, Amouheidari A, Shahbazi-Gahrouei D, Baradaran-Ghahfarokhi HR, et al
Evaluation of the Effects of Prostate Radiation Therapy on Occludin Expression and Ultrasonography Characteristics of the Bladder.
Int J Radiat Oncol Biol Phys. 2017;99:963-971.
PubMed Text format Abstract available

MARTELL K, Husain S, Taussky D, Angyalfi S, et al
Multicenter Evaluation of Biochemical Relapse-Free Survival Outcomes for Intraoperatively Planned Prostate Brachytherapy Using an Automated Delivery System.
Int J Radiat Oncol Biol Phys. 2017;99:895-903.
PubMed Text format Abstract available

GUPTA SK, Watson T, Denham J, Shakespeare TP, et al
Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography for Prostate Cancer: Distribution of Disease and Implications for Radiation Therapy Planning.
Int J Radiat Oncol Biol Phys. 2017;99:701-709.
PubMed Text format Abstract available

DATTA NR, Stutz E, Rogers S, Bodis S, et al
Conventional Versus Hypofractionated Radiation Therapy for Localized or Locally Advanced Prostate Cancer: A Systematic Review and Meta-analysis along with Therapeutic Implications.
Int J Radiat Oncol Biol Phys. 2017;99:573-589.
PubMed Text format Abstract available

CHOUDHURY A
ProtecTing Low-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2017;99:515-517.
PubMed Text format

BERLIN A, Ahmad AE, Chua MLK, Moraes FY, et al
Curative Radiation Therapy at Time of Progression Under Active Surveillance Compared With Up-Front Radical Radiation Therapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2017 Nov 1. pii: S0360-3016(17)34048.
PubMed Text format Abstract available

October 2017

ADJEIWAAH M, Bylund M, Lundman JA, Karlsson CT, et al
Quantifying the Effect of 3T Magnetic Resonance Imaging Residual System Distortions and Patient-Induced Susceptibility Distortions on Radiation Therapy Treatment Planning for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2017 Oct 20. pii: S0360-3016(17)34027.
PubMed Text format Abstract available

FRANK SJ, Pugh TJ, Blanchard P, Mahmood U, et al
Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes.
Int J Radiat Oncol Biol Phys. 2017 Oct 12. pii: S0360-3016(17)33968.
PubMed Text format Abstract available

ECHEVARRIA MI, Naghavi AO, Abuodeh YA, Ahmed KA, et al
Low-dose-rate Brachytherapy for Prostate Cancer in Low-resource Settings.
Int J Radiat Oncol Biol Phys. 2017;99:378-382.
PubMed Text format Abstract available

PINKAWA M, Berneking V, Schlenter M, Krenkel B, et al
Quality of Life After Radiation Therapy for Prostate Cancer With a Hydrogel Spacer: 5-Year Results.
Int J Radiat Oncol Biol Phys. 2017;99:374-377.
PubMed Text format Abstract available

September 2017

KEAM SP, Caramia F, Gamell C, Paul PJ, et al
The Transcriptional Landscape of Radiation-Treated Human Prostate Cancer: Analysis of a Prospective Tissue Cohort.
Int J Radiat Oncol Biol Phys. 2017 Sep 25. pii: S0360-3016(17)33937.
PubMed Text format Abstract available

KERSHAW L, van Zadelhoff L, Heemsbergen W, Pos F, et al
Image Guided Radiation Therapy Strategies for Pelvic Lymph Node Irradiation in High-Risk Prostate Cancer: Motion and Margins.
Int J Radiat Oncol Biol Phys. 2017 Sep 8. pii: S0360-3016(17)33841.
PubMed Text format Abstract available

PICKLES T, Tyldesley S, Hamm J, Virani SA, et al
Brachytherapy for Intermediate-Risk Prostate Cancer, Androgen Deprivation, and the Risk of Death.
Int J Radiat Oncol Biol Phys. 2017 Sep 4. pii: S0360-3016(17)33839.
PubMed Text format Abstract available

DAYES IS, Parpia S, Gilbert J, Julian JA, et al
Long-Term Results of a Randomized Trial Comparing Iridium Implant Plus External Beam Radiation Therapy With External Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the Prostate.
Int J Radiat Oncol Biol Phys. 2017;99:90-93.
PubMed Text format Abstract available

SUJENTHIRAN A, Nossiter J, Charman SC, Parry M, et al
National Population-Based Study Comparing Treatment-Related Toxicity in Men Who Received Intensity Modulated Versus 3-Dimensional Conformal Radical Radiation Therapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2017 Sep 1. pii: S0360-3016(17)33654.
PubMed Text format Abstract available

August 2017

AGGARWAL A, Lewis D, Sujenthiran A, Charman SC, et al
Hospital Quality Factors Influencing the Mobility of Patients for Radical Prostate Cancer Radiation Therapy: A National Population-Based Study.
Int J Radiat Oncol Biol Phys. 2017 Aug 24. pii: S0360-3016(17)33774.
PubMed Text format Abstract available

REIS FERREIRA M, Khan A, Thomas K, Truelove L, et al
Phase 1/2 Dose-Escalation Study of the Use of Intensity Modulated Radiation Therapy to Treat the Prostate and Pelvic Nodes in Patients With Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2017 Aug 2. pii: S0360-3016(17)33655.
PubMed Text format Abstract available

MALLA B, Zaugg K, Vassella E, Aebersold DM, et al
Exosomes and Exosomal MicroRNAs in Prostate Cancer Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2017;98:982-995.
PubMed Text format Abstract available

GLASER SM, Chen KS, Benoit RM, Smith RP, et al
Long-Term Quality of Life in Prostate Cancer Patients Treated With Cesium-131.
Int J Radiat Oncol Biol Phys. 2017;98:1053-1058.
PubMed Text format Abstract available

WANG C, Kishan AU, Kamrava M, Steinberg ML, et al
External Beam Radiation Therapy With a Brachytherapy Boost Versus Radical Prostatectomy in Gleason Pattern 5 Prostate Cancer: A Population-Based Cohort Study.
Int J Radiat Oncol Biol Phys. 2017;98:1045-1052.
PubMed Text format Abstract available

BEN-JOSEF AM, Chen J, Wileyto P, Doucette A, et al
Effect of Eischens Yoga During Radiation Therapy on Prostate Cancer Patient Symptoms and Quality of Life: A Randomized Phase II Trial.
Int J Radiat Oncol Biol Phys. 2017;98:1036-1044.
PubMed Text format Abstract available

July 2017

FANG P, He W, Gomez DR, Hoffman KE, et al
Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States.
Int J Radiat Oncol Biol Phys. 2017;98:748-757.
PubMed Text format Abstract available

MIDDELBURG JG, Mast ME, de Kroon M, Jobsen JJ, et al
Timed Get Up and Go Test and Geriatric 8 Scores and the Association With (Chemo-)Radiation Therapy Noncompliance and Acute Toxicity in Elderly Cancer Patients.
Int J Radiat Oncol Biol Phys. 2017;98:843-849.
PubMed Text format Abstract available

SONG YP, Ellis T, Walshaw R, Mbanu P, et al
Comparing Clinical Outcomes for Radium-223: Do Older Patients Do Worse?
Int J Radiat Oncol Biol Phys. 2017;98:955-957.
PubMed Text format Abstract available

WAHL DR, Nguyen PL, Santiago M, Yousefi K, et al
Pan-Cancer Analysis of Genomic Sequencing Among the Elderly.
Int J Radiat Oncol Biol Phys. 2017;98:726-732.
PubMed Text format Abstract available

MOROTE J, Tabernero AJ, Alvarez Ossorio JL, Ciria JP, et al
Cognitive Function in Patients With Prostate Cancer Receiving Luteinizing Hormone-Releasing Hormone Analogues: A Prospective, Observational, Multicenter Study.
Int J Radiat Oncol Biol Phys. 2017;98:590-594.
PubMed Text format Abstract available

RODDA S, Morris WJ, Hamm J, Duncan G, et al
ASCENDE-RT: An Analysis of Health-Related Quality of Life for a Randomized Trial Comparing Low-Dose-Rate Brachytherapy Boost With Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2017;98:581-589.
PubMed Text format Abstract available

CORKUM MT
Prostate Cancer With Isolated Bony Metastasis: Sternal Struggle.
Int J Radiat Oncol Biol Phys. 2017;98:492-493.
PubMed Text format

SIVA S
Prostate-Specific Membrane Antigen PET Before Aggressive Local Therapy to the Sternum.
Int J Radiat Oncol Biol Phys. 2017;98:494-495.
PubMed Text format

June 2017

DADKHAH H, Hopfensperger KM, Kim Y, Wu X, et al
Multisource Rotating Shield Brachytherapy Apparatus for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2017 Jun 20. pii: S0360-3016(17)31057.
PubMed Text format Abstract available

SHENG Y, Li T, Lee WR, Yin FF, et al
Exploring the Margin Recipe for Online Adaptive Radiation Therapy for Intermediate-Risk Prostate Cancer: An Intrafractional Seminal Vesicles Motion Analysis.
Int J Radiat Oncol Biol Phys. 2017;98:473-480.
PubMed Text format Abstract available

YANG DD, Muralidhar V, Mahal BA, Labe SA, et al
National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2017;98:338-343.
PubMed Text format Abstract available

O'CALLAGHAN ME, Raymond E, Campbell JM, Vincent AD, et al
Patient-Reported Outcomes After Radiation Therapy in Men With Prostate Cancer: A Systematic Review of Prognostic Tool Accuracy and Validity.
Int J Radiat Oncol Biol Phys. 2017;98:318-337.
PubMed Text format Abstract available

LAWTON CAF, Lin X, Hanks GE, Lepor H, et al
Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202.
Int J Radiat Oncol Biol Phys. 2017;98:296-303.
PubMed Text format Abstract available

SPRATT DE, Jagsi R
Breast and Prostate Cancer: Lessons to Be Shared.
Int J Radiat Oncol Biol Phys. 2017;98:263-268.
PubMed Text format

CHARGARI C, Haie-Meder C, Guerin F, Minard-Colin V, et al
Brachytherapy Combined With Surgery for Conservative Treatment of Children With Bladder Neck and/or Prostate Rhabdomyosarcoma.
Int J Radiat Oncol Biol Phys. 2017;98:352-359.
PubMed Text format Abstract available

GAY HA, Sanda MG, Liu J, Wu N, et al
External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy: Results of a Multicenter, Prospective Study of Quality of Life.
Int J Radiat Oncol Biol Phys. 2017;98:304-317.
PubMed Text format Abstract available

May 2017

HAUCK CR, Ye H, Chen PY, Gustafson GS, et al
Increasing Fractional Doses Increases the Probability of Benign PSA Bounce in Patients Undergoing Definitive HDR Brachytherapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2017;98:108-114.
PubMed Text format Abstract available

GESTAUT MM, Cai W, Vyas S, Patel BJ, et al
Low-Dose-Rate Brachytherapy Versus Cryotherapy in Low- and Intermediate-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2017;98:101-107.
PubMed Text format Abstract available

CHEN WS, Townsend JP, Yu JB
Radiation-Specific Clinical Data Should Be Included in Existing Large-Scale Genomic Datasets.
Int J Radiat Oncol Biol Phys. 2017;98:8-10.
PubMed Text format

April 2017

KANOUN S, Walker P, Vrigneaud JM, Depardon E, et al
18F-Choline Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging for the Detection of Early Local Recurrence of Prostate Cancer Initially Treated by Radiation Therapy: Comparison With Systematic 3-Dimensional
Int J Radiat Oncol Biol Phys. 2017;97:986-994.
PubMed Text format Abstract available

CIEZKI JP, Weller M, Reddy CA, Kittel J, et al
A Comparison Between Low-Dose-Rate Brachytherapy With or Without Androgen Deprivation, External Beam Radiation Therapy With or Without Androgen Deprivation, and Radical Prostatectomy With or Without Adjuvant or Salvage Radiation Therapy for High-Risk
Int J Radiat Oncol Biol Phys. 2017;97:962-975.
PubMed Text format Abstract available

YOSHIOKA Y, Kotsuma T, Komiya A, Kariya S, et al
Nationwide, Multicenter, Retrospective Study on High-Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2017;97:952-961.
PubMed Text format Abstract available

BOSCO C, Garmo H, Adolfsson J, Stattin P, et al
Prostate Cancer Radiation Therapy and Risk of Thromboembolic Events.
Int J Radiat Oncol Biol Phys. 2017;97:1026-1031.
PubMed Text format Abstract available

SCHILD MH, Schild SE, Wong WW, Vora SA, et al
A Prospective Trial of Intensity Modulated Radiation Therapy (IMRT) Incorporating a Simultaneous Integrated Boost for Prostate Cancer: Long-term Outcomes Compared With Standard Image Guided IMRT.
Int J Radiat Oncol Biol Phys. 2017;97:1021-1025.
PubMed Text format Abstract available

REED A, Valle LF, Shankavaram U, Krauze A, et al
Effect of Prostate Magnetic Resonance Imaging/Ultrasound Fusion-guided Biopsy on Radiation Treatment Recommendations.
Int J Radiat Oncol Biol Phys. 2017;97:947-951.
PubMed Text format Abstract available

HAMSTRA DA, Mariados N, Sylvester J, Shah D, et al
Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial.
Int J Radiat Oncol Biol Phys. 2017;97:976-985.
PubMed Text format Abstract available

March 2017

SHAIKH T, Li T, Handorf EA, Johnson ME, et al
Long-Term Patient-Reported Outcomes From a Phase 3 Randomized Prospective Trial of Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2017;97:722-731.
PubMed Text format Abstract available

BEKELMAN JE, Lee WR
Six Questions to Ask Before We Shorten Radiation Treatments for Intact Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2017;97:718-721.
PubMed Text format

SIMON A, Le Maitre A, Nassef M, Rigaud B, et al
Is Dose Deformation-Invariance Hypothesis Verified in Prostate IGRT?
Int J Radiat Oncol Biol Phys. 2017;97:830-838.
PubMed Text format Abstract available

NICOLAE A, Morton G, Chung H, Loblaw A, et al
Evaluation of a Machine-Learning Algorithm for Treatment Planning in Prostate Low-Dose-Rate Brachytherapy.
Int J Radiat Oncol Biol Phys. 2017;97:822-829.
PubMed Text format Abstract available

SHAVERDIAN N, Verruttipong D, Wang PC, Kishan AU, et al
Exploring Value From the Patient's Perspective Between Modern Radiation Therapy Modalities for Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2017;97:516-525.
PubMed Text format Abstract available

MIRHADI AJ, Zhang Q, Hanks GE, Lepor H, et al
Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202.
Int J Radiat Oncol Biol Phys. 2017;97:511-515.
PubMed Text format Abstract available

HOLCH P, Henry AM, Davidson S, Gilbert A, et al
Acute and Late Adverse Events Associated With Radical Radiation Therapy Prostate Cancer Treatment: A Systematic Review of Clinician and Patient Toxicity Reporting in Randomized Controlled Trials.
Int J Radiat Oncol Biol Phys. 2017;97:495-510.
PubMed Text format Abstract available

MIKSYS N, Vigneault E, Martin AG, Beaulieu L, et al
Large-scale Retrospective Monte Carlo Dosimetric Study for Permanent Implant Prostate Brachytherapy.
Int J Radiat Oncol Biol Phys. 2017;97:606-615.
PubMed Text format Abstract available

PARKER WP, Evans JD, Stish BJ, Park SS, et al
Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography.
Int J Radiat Oncol Biol Phys. 2017;97:526-535.
PubMed Text format Abstract available

February 2017

GRIVAS N, Wit E, Pos F, de Jong J, et al
Sentinel Lymph Node Dissection to Select Clinically Node-negative Prostate Cancer Patients for Pelvic Radiation Therapy: Effect on Biochemical Recurrence and Systemic Progression.
Int J Radiat Oncol Biol Phys. 2017;97:347-354.
PubMed Text format Abstract available

YAHYA N, Ebert MA, House MJ, Kennedy A, et al
Modeling Urinary Dysfunction After External Beam Radiation Therapy of the Prostate Using Bladder Dose-Surface Maps: Evidence of Spatially Variable Response of the Bladder Surface.
Int J Radiat Oncol Biol Phys. 2017;97:420-426.
PubMed Text format Abstract available

MISHRA MV, Aggarwal S, Bentzen SM, Knight N, et al
Establishing Evidence-Based Indications for Proton Therapy: An Overview of Current Clinical Trials.
Int J Radiat Oncol Biol Phys. 2017;97:228-235.
PubMed Text format Abstract available

PISANSKY TM, Tendulkar RD
In Reply to Ghadjar et al.
Int J Radiat Oncol Biol Phys. 2017;97:439-440.
PubMed Text format

January 2017

RODDA S, Tyldesley S, Morris WJ, Keyes M, et al
ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2017 Jan 6. pii: S0360-3016(17)30008.
PubMed Text format Abstract available

KRAUSS DJ, Ye H, Martinez AA, Mitchell B, et al
Favorable Preliminary Outcomes for Men With Low- and Intermediate-risk Prostate Cancer Treated With 19-Gy Single-fraction High-dose-rate Brachytherapy.
Int J Radiat Oncol Biol Phys. 2017;97:98-106.
PubMed Text format Abstract available

PINKAWA M
Zoledronic Acid in First-Line Treatment of Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2017;97:6-8.
PubMed Text format

November 2016

MORRIS WJ, Tyldesley S, Rodda S, Halperin R, et al
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boo
Int J Radiat Oncol Biol Phys. 2016 Nov 24. pii: S0360-3016(16)33484.
PubMed Text format Abstract available

ROSE BS, Chen MH, Wu J, Braccioforte MH, et al
Androgen Deprivation Therapy Use in the Setting of High-dose Radiation Therapy and the Risk of Prostate Cancer-Specific Mortality Stratified by the Extent of Competing Mortality.
Int J Radiat Oncol Biol Phys. 2016;96:778-784.
PubMed Text format Abstract available

NAIK M, Reddy CA, Stephans KL, Ciezki JP, et al
Posttreatment Prostate-Specific Antigen 6 Months After Radiation With Androgen Deprivation Therapy Predicts for Distant Metastasis-Free Survival and Prostate Cancer-Specific Mortality.
Int J Radiat Oncol Biol Phys. 2016;96:617-23.
PubMed Text format Abstract available

October 2016

NARAYAN V, Vapiwala N, Mick R, Subramanian P, et al
Phase 1 Trial of Everolimus and Radiation Therapy for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy.
Int J Radiat Oncol Biol Phys. 2016 Oct 20. pii: S0360-3016(16)33333.
PubMed Text format Abstract available

ZAPATERO A, Guerrero A, Maldonado X, Alvarez A, et al
Late Radiation and Cardiovascular Adverse Effects After Androgen Deprivation and High-Dose Radiation Therapy in Prostate Cancer: Results From the DART 01/05 Randomized Phase 3 Trial.
Int J Radiat Oncol Biol Phys. 2016;96:341-8.
PubMed Text format Abstract available

VAN HEMELRYK A, De Meerleer G, Ost P, Poelaert F, et al
The Outcome for Patients With Pathologic Node-Positive Prostate Cancer Treated With Intensity Modulated Radiation Therapy and Androgen Deprivation Therapy: A Case-Matched Analysis of pN1 and pN0 Patients.
Int J Radiat Oncol Biol Phys. 2016;96:323-32.
PubMed Text format Abstract available

GHIAM AF, Taeb S, Huang X, Jahangiri S, et al
The Biological Role and Clinical Significance of Long Noncoding RNA Urothelial Carcinoma Associated 1 (UCA1) in Prostate Cancer (PCa).
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

GRECO C, Pares O, Pimentel N, Louro V, et al
Phase 1/2 Study of Urethral and Rectal Sparing Following Extreme Hypofractionated (5x9 Gy) Stereotactic Body Radiation Therapy in Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

DESS RT, Jackson WC, Suy S, Lee JY, et al
Predictors of Multidomain Decline in Health-Related Quality of Life After Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

MEIER R, Beckman A, Henning G, Mohideen N, et al
Five-Year Outcomes From a Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

CHEUNG P, Morton G, Szumacher E, Danjoux C, et al
Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost For Localized High-Risk Prostate Cancer: Five-Year Results of a Prospective Trial.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

LIENG H, Pintilie M, Berlin A, Bayley A, et al
Long-Term Outcomes of a Phase 2 Trial of Moderate Hypofractionated Image Guided Intensity Modulated Radiation Therapy (IG-IMRT) for Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

HOFFMAN KE, Voong KR, Levy LB, Pugh TJ, et al
Randomized Trial of Hypofractionated Dose-Escalated Intensity Modulated Radiation Therapy Versus Conventionally Fractionated Intensity Modulated Radiation Therapy for Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

SPRATT DE, Zhao SG, Chang SL, Cooperberg MR, et al
Identification and Validation of Intrinsic Subtypes of Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

KORHONEN J, Visapaa H, Seppala T, Kapanen M, et al
Clinical Experiences of Treating Prostate Cancer Patients With Magnetic Resonance Imaging-Only Based Radiation Therapy Treatment Planning Workflow.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

VAN HERK MB, McWilliam A, Sanderson B, Kennedy J, et al
Toward a Data Mining Approach for Risk Stratification in Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

WATKINS BRUNER D, Pugh SL, Lee WR, Dignam JJ, et al
NRG Oncology/RTOG 0415, Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer: Prostate-Specific Quality of Life Results.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

COULTER JB, Haffner MC, Mian OY, Kim K, et al
Partial Agonist Activity of Hydroxyflutamide Induces AR- and TOP2B-dependent DNA Double Strand Breaks and Radiosensitizes Prostate Cancer Cells.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

VAPIWALA N, Narayan V, Subramanian P, Christodouleas JP, et al
Phase I Trial of Everolimus in Combination with Salvage Radiation Therapy (RT) for Post-prostatectomy Biochemical Recurrence (BCR) in Prostate Cancer (PC) Patients.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

GHIAM AF, Vesprini D, Taeb S, Jahangiri S, et al
Serum Exosomal MicroRNAs (miRNAs) as Noninvasive Biomarkers to Guide Postoperative Radiation Therapy in Prostate Cancer (PCa) Patients Treated With Radical Prostatectomy (RP).
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

KUMAR P, Veldhuizen P, Thompson M, Shen X, et al
Trimodality Therapy Is Tolerable and Feasible in Patients With Postprostatectomy High-Risk Pathologic (p) T2-3N0M0 Prostate Cancer: Results of a Phase 1-2 Trial.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

NABID A, Carrier N, Vigneault E, Souhami L, et al
Second Malignancies as First Cause of Death in Localized Prostate Cancer Treated With Radiation Therapy: Data from Two Phase 3 Trials.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

NOMIYA T, Tsuji H, Kawamura H, Ohno T, et al
A Multi-institutional Analysis of Prospective Studies of Carbon Ion Radiation Therapy for Prostate Cancer: An Analysis of 2157 Patients from the Japan Carbon Ion Radiation Oncology Study Group (J-CROS).
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

BYUN J, Goyal S, Kim IY, Parikh RR, et al
Local Therapy Improves Overall Survival in Patients with Newly Diagnosed Metastatic Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

HELOU J, Torres S, Musunuru HB, Cheung P, et al
Low-Dose-Rate Brachytherapy Versus Standard Fractionated External Beam Radiation Therapy Versus Stereotactic Body Radiation Therapy for Low-Risk Prostate Cancer: A Cost-Utility Analysis.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

FERO KE, Paravati AJ, Panjwani N, Boero IJ, et al
The Impact of Radiation Cost on Patient Outcomes After Definitive Radiation Therapy in Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

LESTER-COLL NH, Johnson S, Magnuson WJ, Yu JB, et al
Assessing Potential Cardiovascular Risk Against the Benefits of Hormonal Therapy in Men With Intermediate-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

ROSE B, Chen MH, Wu J, Braccioforte MH, et al
Androgen Deprivation Therapy Use in the Setting of High-Dose Radiation Therapy and the Risk of Prostate Cancer-Specific Mortality Stratified by the Extent of Competing Mortality.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

ZAPATERO A, Guerrero AD, Maldonado J, Alvarez A, et al
Androgen Deprivation and High-Dose Radiation Therapy in Prostate Cancer: Report on Late Toxicity from DART 01/05 Randomized Phase III Trial.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

JOHNSON SB, Lester-Coll NH, Kelly JR, Yu JB, et al
Comparing Overall Survival for Androgen Suppression and Low-Dose-Rate Brachytherapy Boost Versus Androgen Suppression and External Beam Radiation Boost for Men With Unfavorable Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

SARGOS P, Mottet N, Molinie V, Richaud PM, et al
Long-Term Androgen Deprivation, With or Without Radiation Therapy, in Locally Advanced Prostate Cancer: Results From a Phase 3 Randomized Study After 7.3 Years' Median Follow-up.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

SCHULER JC, Marshall DT
Decreasing Utilization of Brachytherapy as a Boost Modality in the Treatment of High-Risk Prostate Cancer: A National Patterns of Care Analysis.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

HARTSELL WF, Godes D, Ketch TD, Caron J, et al
Proton Therapy in the USA From 2012 to 2014-Increasing Treatment of Pediatric, Lung, Head and Neck, Gastrointestinal, and Breast Cancers, But No Increase in Prostate Cancer Treatments: A Study From the National Association for Proton Therapy.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

DOSANI M, Morris J, Tyldesley S, Pickles T, et al
The Relationship Between Hot Flashes and Testosterone Recovery Following 12 Months of Androgen Suppression for Men With Localized Prostate Cancer in a Randomized Trial.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

REPKA MC, Kole TP, Wu B, Tong M, et al
Effect of Dose to the Bladder Wall and Trigone on Late Urinary Flare Following Definitive Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

CHUA ML, Salcedo A, Meng A, Zhang J, et al
Genomic Architecture of Prostate Cancer at Recurrence Following Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

SO J, Chua ML, Lalonde E, Pra AD, et al
Prognostic Significance of Tonsil Expression and the Homologous Recombination Pathway in Intermediate-Risk Prostate Cancer Recurrence.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

NGUYEN PL, Martin NE, Palmer-Aronsten BJ, Choeurng V, et al
The Use of a Biopsy-Based Genomic Classifier to Predict the Risk of Distant Metastasis After Definitive Radiation and Short-Course Androgen Deprivation Therapy for Intermediate- and High-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

BACH-GANSMO T, Nanni C, Nieh P, Zanoni L, et al
Staging of Biochemically Relapsing Prostate Cancer Using the Positron Emission Tomography Tracer Fluciclovine F18.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

PARKER WP, Davis BJ, Park SS, Olivier K, et al
Patterns of Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: Unique Identification of Sites of Recurrence Impacting Clinical Management.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

AMIT U, Goldstein JD, Davidson T, Hahiashvili M, et al
The Role of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography in the Management of Patients With Prostate Cancer: Implications for Selection of Patients for Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

SHEN C, Minn I, Chen Y, Mease RC, et al
Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen in a Micrometastatic Model of Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

BELZ J, Ojo NC, Kumar R, Cormack RA, et al
Docetaxel-Loaded Brachytherapy Spacers for Combined Chemoradiation Therapy in Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

ZHAO SG, Chang SL, Spratt DE, Erho NG, et al
A 24-Gene Predictor of Response to Postoperative Radiation Therapy in Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

WONG AT, Schwartz D, Osborn V, Safdieh J, et al
Adjuvant Radiation With Hormonal Therapy Is Associated With Improved Survival for Men With Pathologically Involved Lymph Nodes Following Radical Surgery for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

RAMEY SJ, Abramowitz MC, Moghanaki D, Agrawal S, et al
Benefit of Elective Nodal Irradiation and Androgen Deprivation Therapy with Postprostatectomy Salvage Radiation Therapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

AGRAWAL S, Stephenson AJ, Michalski J, Efstathiou JA, et al
Prostate Cancer-Specific Mortality and Survival Outcomes for Salvage Radiation Therapy After Radical Prostatectomy.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

KEALL P, Colvill E, Eade T, Juneja P, et al
Primary and Secondary Outcome Measure Results From the First Prospective Clinical Trial of Electromagnetic-Guided MLC Tracking Radiation Therapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

YASMIN-KARIM S, Moreau M, Ngwa W
In Vitro Study of Small-Sized Nanoparticle-Aided Radiation Therapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

GALLAHER IS, Johnson J, Wang X
Novel Technique Using Full-Dose Low-Dose-Rate Brachytherapy With Field-Matched Pelvic Intensity Modulated Radiation Therapy for High-Risk Prostate Cancer Improves Rectal Sparing.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

ZHANG J, Ates O, Li A
Implementation of a Machine Learning-Based Automatic Contour Quality Assurance Tool for Online Adaptive Radiation Therapy of Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

CHRISTIANSEN RL, Jensen HR, Brink C
Magnetic Resonance-Only Workflow and Validation of Magnetic Resonance-Based Dose Calculations for Radiation Therapy of Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

STAPOR-FUDZINSKA M, Tarnawski RR, Wydmanski J, Napieralska A, et al
Doses Delivered to Testes Using Automatic Treatment Plan Optimization for Patients With Low-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

LEE S, Kim KH, Cao YJ, Shim JB, et al
A Study of Acute Genitourinary and Gastrointestinal Toxicity Relationship With Planning Index in Prostate Cancer Treated by Helical Tomotherapy.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

KOIVULA L, Wee L, Korhonen J
Proton Therapy Treatment Planning With MRI Only: Dose Calculation Accuracy in MRI-Derived Substitute Computed Tomography Images for Brain Tumor and Prostate Cancer Treatments.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

WEN N, Bagher-Ebadian H, Pantelic M, Hearshen D, et al
A Physiologically Nested Pharmacokinetic Model in Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Detection of Dominant Intraprostatic Lesions in Patients With Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

BYUN DJ, Happersett L, Zhang P, Pei X, et al
Variation in Interfractional Bladder Volume during Hypofractionated Radiation Therapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

YANG X, Jani A, Rossi PJ, Mao H, et al
Multiparametric Magnetic Resonance Imaging Guided Radiation Therapy for Prostate Cancer Using Learning-Based Magnetic Resonance Imaging-Computed Tomography Registration.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

BALDWIN P, Van De Ven AL, Seitzer N, Clohessy S, et al
Nanoformulation of the PARP Inhibitor Olaparib Enables Radiosensitization of a Radiation-Resistant Prostate Cancer Model.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

MAHMOOD J, Murti SC, Zaveri SR, Shukla HD, et al
Caveolin-1: A Novel Prognostic Biomarker for Radioresistance in Non-Small Cell Lung Carcinoma (NSCLC) and Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

TAUNK NK, Zhang H, Carlin S, Weber W, et al
Monitoring Prostate Cancer Treatment Response to Radiation Therapy and Androgen Deprivation With Novel Radiolabeled and Dual-Labeled Gastrin-Releasing Peptide Receptor (GRPr) Antagonists.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

WIDLAK P, Pietrowska M, Jelonek K, Ros M, et al
Radiation Therapy-Related Changes in Serum Proteome and Lipidome Are Primarily Associated With a Type of Acute Toxicity: Comparison of Radiation-Induced Effects in Patients Treated Because of Head and Neck Cancer or Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

YAMOAH K, Lal P, Mahajan S, Naghavi AO, et al
Clinical Implications of TMPRSS2-ERG Fusion in African American Men With Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

PATEL VL, Busch E, D'Amico AV, Rebbeck TR, et al
BRCA2 Mutations in Prostate Cancer Assort Into Cluster Regions.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

BLANCHARD P, Davis JW, Frank SJ, Jeri K, et al
How to Counsel Patients With Localized Prostate Cancer About Treatment Selection: Quality-of-Life Results of a Prospective Single-Institution Cohort.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

VIGNEAULT E, Savard J, Ivers H, Savard MH, et al
Validation of a French-Canadian Version of the Expanded Prostate Cancer Index Composite Instrument (EPIC).
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

BROUGHMAN JR, Basak R, Dickerson GA, Usinger DS, et al
Comparative Quality of Life Outcomes Among Brachytherapy, Intensity Modulated Radiation Therapy (IMRT), and Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer-Analysis of a Multi-Institutional Prospective Cohort.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

AL-HANAQTA MM, Loblaw DA, Chung HT, Cheung P, et al
Single 19-Gy High-Dose-Rate Brachytherapy Monotherapy for Treatment of Prostate Cancer: Tolerability and Dosimetric Predictors of Acute Toxicity and Health-Related Quality of Life.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

SZUMACHER E, Dawdy K, Bonin K, Russell S, et al
Empowering Patients Through Education-Development and Evaluation of a Multimedia Patient Education Tool to Ensure Patient Preparedness for Planning CT Scan for Prostate Cancer (Randomized Study).
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

ECHEVARRIA M, Naghavi AO, Abuodeh YA, Chevere CM, et al
Low-Dose-Rate Brachytherapy for Prostate Cancer in Low Resource Settings.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

KOVTUN K, Chen MH, Braccioforte MH, Moran BJ, et al
Race and the Risk of Death Following High-Dose Radiation Therapy in Men Treated With or Without Androgen Suppression Therapy for Favorable-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

FRANK SJ, Pugh TJ, Mahmood U, Blanchard P, et al
The Value of Brachytherapy for Intermediate-Risk Localized Prostate Cancer Using Ichom Outcomes and Time-Driven Activity-Based Costing: Results From a Phase 2 Prospective Trial of 300 Patients.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

MAHAL A, Mahal BA, Singh R, Green AR, et al
The Effect of Race and Decision Aids on Physician Recommendation for Prostate Cancer Treatment Planning.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

KIM HJ, Kim WC
Prostate-Specific Antigen Kinetics After Hypofractionated Stereotactic Body Radiation Therapy Boost and Whole-Pelvic Radiation Therapy for Intermediate- and High-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

FREIBERGER C, Schmitt V, Eble MJ, Pinkawa M, et al
Prognostic Significance of Rising Prostate-Specific Antigen (PSA) Levels Following Radiation Therapy for Localized Prostate Cancer-Comparison Between PSA Bounce Versus PSA Recurrence.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

BOLADERAS A, Ferrer F, Navarro V, De Blas R, et al
Association Between Dose-Volume Histograms and Health-Related Quality of Life in Patients with Prostate Cancer Treated with External Beam Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

HATTORI Y, Nakanishi M, Hashimoto S, Iwata H, et al
How Did Sexual Function and Serum Testosterone Level Change in Patients With Prostate Cancer After Proton Therapy?
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

GESTAUT MM, Pruszynski J, Swanson GP
Prostate Cancer in Patients With High Prostate-Specific Antigen But Otherwise Very Low-Risk Disease Behaves Like Prostate Cancer in High-Risk Patients.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

WANG J, Zhao D, Veruttipong D, Kupelian PA, et al
Combined Pretreatment Serum Testosterone Concentration and Risk Stratification Enhances Interpretation of Prostate-Specific Antigen (PSA) Kinetics in Localized Prostate Cancer After Stereotactic Body Radiation Therapy (SBRT).
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

SHAO M, Osborn V, Lederman AJ, Lee A, et al
Impact of Current or Prior Smoking Use for Men Receiving External Beam Radiation for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

ARORA D, Schurr R, Zhang F, Gestaut MM, et al
The Effect of Comprehensive Pelvic Nodal Radiation in Prostate Cancer on the CBC.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

FINKELSTEIN SE, Forman J, Fernandez E, Chen CT, et al
Multicenter Assessment of Stereotactic Body Radiation Therapy (SBRT) Boost in Intermediate-Risk Prostate Cancer: Biochemical Failure and Toxicity.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

SCOBIOALA S, Kittel C, Haverkamp U, Channaoui M, et al
A Dosimetric Comparison Between Conventionally Fractionated Tomotherapy, Volumetric Modulated Arc Therapy, Sliding Window and Proton Therapy, and Hypofractionated Robotic Radiosurgery Treatment by Low-Risk Prostate Carcinoma.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

ZAORSKY NG, Handorf E, Horwitz EM, Hallman MA, et al
Pretreatment Predictors of Receiving Adjuvant Radiation Therapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

FAGUNDES MA, Price SG, Robison B, Case S, et al
Evolving Rectal Sparing in Fiducial-Based Image Guided Proton Therapy for Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

AVUZZI B, Cozzarini C, Rancati T, Improta I, et al
What Happens to Testosterone Levels After Radical Radiation Therapy for Prostate Cancer?
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

FISCHER-VALUCK BW, Gay HA, Michalski J
Magnetic Resonance Image Guided Radiation Therapy (MR-IGRT) for the Treatment of Prostate Cancer: Initial Clinical Experience and Patient Selection.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

GALALAE R, Schroeder C, Geiger F, Siebert FA, et al
Superiority of Real-Time Adaptive Interstitial High-Dose-Rate Brachytherapy for Localized Prostate Cancer-Five- and 8-Year Outcomes of Kiel University Hospital Protocols.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

CASCALES GARCIA MA, Colmenero M, Rodriguez Antolin A, Samper Ots PM, et al
Measuring Quality of Life in Low-Risk Prostate Cancer Treated With Surgery, External Beam Radiation Therapy, or Brachytherapy. CAPCIRAB Project: A Prospective, Multicentric Cohort Study.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

TAKEMOTO S, Shibamoto Y, Sugie C, Manabe Y, et al
Long-Term Results of Intensity Modulated Radiation Therapy With 3 Dose-Fractionation Regimens for Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

KIM HJ, Kim WC
Prostate-Specific Antigen Kinetics After Hypofractionated Stereotactic Body Radiation Therapy Boost as Post-External Beam Radiation Therapy (EBRT) Versus Conventionally Fractionated EBRT for Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

LEVINE R, Russo S, Su LM, Stringer T, et al
An Evaluation the Implementation of Evidence-Based Quality Improvement Metrics for Prostate Cancer Management in a Multidisciplinary Tertiary Care Setting.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

NAKAMURA K, Mizowaki T, Inokuchi H, Ikeda I, et al
A Pilot Study of Hypofractionated Intensity Modulated Radiation Therapy Over 3 Weeks for Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

NICHOLS RC, Morris CG, Bryant CM, Hoppe BS, et al
Changes in Serum Testosterone 60 Months After Proton Therapy for Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

FISCHER-VALUCK BW, Mazur TR, Gay HA, Olsen LA, et al
A Treatment Planning Comparison of Proton Therapy and Intensity Modulated Radiation Therapy (IMRT) for Prostate Cancer Using the Normal Tissue Complication Probability (NTCP).
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

TSVANG L, Dubouloz A, Alezra D, Symon Z, et al
Meeting Dose Objectives in Stereotactic Body Radiation Therapy for Prostate Cancer: Water- Versus Air-Filled Endorectal Balloon?
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

WOJCIESZEK PA, Szlag M, Glowacki G, Cholewka A, et al
Intermediate-Risk Prostate Cancer Treated With 3 Radioablative Regimens: Comparison of Robotic Ultrahypofractionation and High-Dose-Rate Brachytherapy Alone or Combined With External Beam Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

SAMLALI H, Udrescu C, Enachescu C, Yossi S, et al
Prospective Evaluation of a Specific Technique of Sexual Function Preservation in External Beam Radiation Therapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

QI X, Gao XS, Li H, Qin SB, et al
Initial Outcome of Definitive Intensity Modulated Radiation Therapy in Treatment of Bone Oligometastatic Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

YE H, Blas KG, Yan D, Brabbins DS, et al
A Matched Comparison of Patients Treated With Standard Dose External Beam Radiation Versus Dose-Escalated, Adaptive, Image Guided External Beam Radiation for Favorable Intermediate-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

GOFF PH, Harrison LB, Furhang EE, Trichter F, et al
Fiducial Marker-Based 2-Dimensional kV Orthogonal Imaging Is More Reliable for Adjusting Interfractional Shifts Than Soft Tissue-Based Cone Beam Computed Tomography for Image Guided IMRT for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

SOAIDA SM, Mulla Z, El Sayed ME, Soliman OY, et al
Image Guided Radiation Therapy Treatment Using Daily Versus Weekly Cone Beam Computed Tomography for Intensity Modulated Radiation Therapy of Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

JOSEPH N, Rancati T, Cicchetti A, Valdagni R, et al
A Higher Whole-Pelvic Integral Dose Is Associated With Worsening Fatigue and Functional Outcome in Prostate Cancer Patients Treated With Intensity Modulated Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

LEE HS, Park W, Pyo HR, Kim CK, et al
The Clinical Impact of Tumor Response on Magnetic Resonance Imaging After Salvage Radiation Therapy for Locally Recurrent Prostate Cancer After Radical Prostatectomy.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

GREER MD, Valle L, Madan RA, Krauze AV, et al
Magnetic Resonance Imaging Findings Associated With Urinary Symptoms After Intensity Modulated Radiation Therapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

MALOUFF T, Walters RW, Marsh S, Silberstein P, et al
Comparison of External Beam Radiation Therapy (EBRT) Techniques on Survival in Stage IIA Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

BAYDOUN A, Traughber B, Morris N, McGraw M, et al
Outcomes and Toxicities in Patients Treated With Definitive Focal Therapy for Primary Prostate Cancer: A Systematic Review.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

HENKENBERENS C, Bengel F, Wester HJ, Christiansen H, et al
Early Efficacy of68ga-PSMA Ligand Positron Emission Tomography/Computed Tomography-Based Radiation Treatment in Locally Recurrent and Oligometastatic Prostate Cancer After Primary Therapy.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

OKAZAKI E, Ishii K, Hosono M, Ogino R, et al
Postimplant Segmental Dosimetry, Biochemical Relapse, and Toxicity in Patients With Prostate Cancer Treated With Loose Iodine-125 Seeds.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

MALOUFF T, Marsh S, Walters RW, Silberstein P, et al
Long-Term Survival by Method of Brachytherapy in Stage IIA Prostate Cancer: A National Cancer Data Base (NCDB) Analysis.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

ZHU S, Syed J, Holtzman AL, Morris CG, et al
Primary Radiation Therapy for Prostate Cancer in Men Younger Than 60 Years of Age.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

WANG W, Gao XS, Xiong W, Li XY, et al
The Effect and Mechanism of 2'-Hydroxyflavanone's Impact on the Radiosensitization of Prostate Cancer Cells.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

SZUMACHER E, Bristow B, Aldehaim M, Bonin K, et al
Patterns of Care Among Canadian Radiation Oncologists and Urologists Related to Postoperative Radiation Therapy for Patients With Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

FERRER F, Pont A, Letelier HA, Garin O, et al
Early Experience and Quality of Life Comparison in Prostate Cancer Brachytherapy Versus Phase I-II Stereotactic Body Radiation Therapy Trials.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

TAKAGI M, Demizu Y, Fuwa N, Sulaiman NS, et al
Is Neoadjuvant Androgen Deprivation Therapy Necessary for Patients With Intermediate-Risk Prostate Cancer Treated With Proton Therapy?
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

ANSCHER MS, Chang MG, Moghanaki D, Rosu M, et al
The Effect of Lovastatin on Preservation of Erectile Function After Radiation Therapy (RT) for Prostate Cancer: Secondary Analysis of a Prospective Study.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

CHEN L, Cvetkovic D, Wang B, Gupta R, et al
Management of Prostate Cancer Using Magnetic Resonance Guided Pulsed Focused Ultrasound-Mediated Targeted Chemotherapeutic Agent Delivery.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

BANG A, Malone S, Leung EY, Canil C, et al
Radium-223 in Metastatic Castration-Resistant Prostate Cancer: Single-Institution Analysis of Factors Associated With Treatment Completion and Survival.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

LU SM, Cosmatos H, Finley DS, Kim DW, et al
Predictors of Biochemical Control Following Salvage Cryotherapy for Radiorecurrent Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

DIBIASE SJ, Srivastav S
The Influence of Treatment Energy on Cardiac Devices in Patients Undergoing Intensity Modulated Radiation Therapy (IMRT) for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

WANG EH, Abouassaly R, Yu JB, Meropol NJ, et al
Disparities in Access and Treatment of Patients With High-Risk Prostate Cancer: Results From a Population-Based Cohort.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

RANCATI T, Improta I, Palorini F, Cozzarini C, et al
Local Dose Descriptors Correlated With Late Urinary Toxicity at 6 to 24 Months After Radiation Therapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

FOLEY K, Groome P, Feldman-Stewart D, Brundage M, et al
Measuring the Quality of Personal Care in Patients Undergoing Radiation Therapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

BOYER MJ, Rushing C, Peterson B, Papagikos MA, et al
Toxicity and Quality of Life Report of a Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) for Low- and Intermediate-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

MURALIDHAR V, Nezolosky MD, Chen YW, Martin NE, et al
Adverse Pathologic Features Following Prostatectomy for Favorable High-Risk Versus Other High-Risk Prostate Cancer: Implications for Choice of Local Therapy.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

ANDERSON E, Wong WW, Mohammadi H, Daniels TB, et al
Predictors for Survival After Radium-223 Treatment for Castration-Resistant Metastatic Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

LIU J, Sasamoto R, Kaidu M, Ayukawa F, et al
High-Dose-Rate Brachytherapy in Which 2 Fractions Were Administered Within a Single Day Combined With External Beam Radiation Therapy for Prostate Cancer: Four-year Experience and Outcomes.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

LAUCHE O, Delouya G, Taussky D, Beliveau-Nadeau D, et al
Single-Fraction High-Dose-Rate Brachytherapy Using Real-Time Transrectal Ultrasound-Based Planning in Combination With External Beam Radiation Therapy for Prostate Cancer: Dosimetrics and Early Clinical Results.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

ZAMBOGLOU C, Schiller F, Fechter T, Drendel V, et al
A Voxel-Wise Comparison of68ga-Hbed-CC-PSMA PET/CT Versus Histopathology in Primary Localized Prostate Cancer: Implementations for Radiation Therapy Treatment Planning.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

GU X, Gao X
Association Between IL-6 -174G>C Polymorphism and Risk of Prostate Cancer: A Meta-Analysis.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

GUNNLAUGSSON A, Kjellen E, Blom R, Bratt O, et al
Prospective Prediction Model Using Prostate-Specific Antigen During Salvage Radiation Therapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

DEN RB, Davicioni E, Takhar M, Erho NG, et al
The Frequency of Druggable Targets in Localized Prostate Cancer: Initial Analysis From a Commercially Available Genomic Expression Database in Urologic Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

KATZ A, Kang J
Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Risk Stratification for Intermediate- and High-Risk Patients.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

GOMEZ-ITURRIAGA A, Casquero F, Fernandez I, Rodeno E, et al
Outcomes After a First and/or Second Salvage Treatment in Patients With Oligometastatic Prostate Cancer Recurrence Detected by (18-F) Choline Positron Emission Tomography/Computed Tomography.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

FERRER F, Ballon K, Boladeras A, De Blas R, et al
Pelvic Volumetric Modulated Arc Therapy (VMAT) for Prostate for Locally Advanced Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

TRAN PT, Radwan N, Ross AE, Reyes D, et al
Stereotactic Ablative Radiation Therapy for the Treatment of Oligometastatic Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

WANG C, Wang J, Pennington JD, Kupelian PA, et al
Racial Disparities in Prostate Cancer-Specific Survival After Definitive Treatment for Gleason 8-10 Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

CVEK J, Knybel L, Skacelikova E, Otahal B, et al
Ultrahypofractionated Stereotactic Radiation Therapy for Low-Intermediate Stage Prostate Cancer-Results From a Single Institution.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

WONG AT, Schwartz D, Lee A, Safdieh J, et al
Patterns of Postprostatectomy Adjuvant Radiation Therapy Utilization for Nonmetastatic Prostate Cancer in a Large, National Cohort.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

DOUCETTE C, Grossman CE, Messing E, Joseph J, et al
High Incidence of Pathologic Upgrading and Upstaging in Clinically Unfavorable Intermediate-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

AMINI A, Kavanagh BD, Raben D, Crawford ED, et al
Proton Beam Therapy Utilization and Disparity in the United States for Treatment of Localized Prostate Cancer: A Study of the National Cancer Data Base.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

STEPHANS KL, Thousand R, Reddy CA, Magnelli A, et al
Heterogeneous Dose-Escalated Prostate Stereotactic Body Radiation Therapy for All Risk Prostate Cancer: An Institutional Phase 2 Study.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

KAWAMURA H, Murata K, Takakusagi Y, Okonogi N, et al
Simultaneous Integrated Boost Intensity Modulated Radiation Therapy for Clinically Node-Positive Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

JOHNSON SB, Soulos PR, Shafman TD, Mantz CA, et al
Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy Versus Moderate Hypofractionation for Clinically Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

SAFDIEH J, Schwartz D, Osborn V, Wong AT, et al
Utilization of Prostate Brachytherapy for Low-Risk Prostate Cancer: Is the Decline Overstated?
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

MURALIDHAR V, Nezolosky MD, Chen YW, Martin NE, et al
National Trends in Androgen Deprivation Therapy Use for Prostate Cancer After Versus Before the Controversy Surrounding Cardiovascular Toxicity.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

ZAPATERO A, Roch M, Buchser D, Castro P, et al
Improved Late Rectal and Urinary Toxicity With High-Dose Intensity Modulated Radiation Therapy Using Intraprostate Fiducial Markers for Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

WANG WG, Yan D, Ye H, Gustafson GS, et al
Outcomes and Toxicity From a Prospective Study of Moderate Hypofractionated Radiation Therapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

JOHNSON SB, Lester-Coll NH, Stahl JM, Nath SK, et al
Impact of Concurrent Androgen-Deprivation Therapy and Radiation Therapy Versus Radiation Therapy Alone on Overall Survival for Men With Unfavorable Intermediate-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

CHOI S, Levy LB, Lee KK, Nguyen QN, et al
Identifying a Subgroup of High-Risk Prostate Cancer Patients With Worse Clinical Outcomes: Should There Be a "Very High-Risk" Group?
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

CHAN J, Rowntree T, Brunt JN, Howard L, et al
Hypofractionated Dose Painting Intensity Modulated Radiation Therapy for Intermediate- to High-Risk Localized Prostate Cancer: Treatment With 20 Fractions.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

TUMATI V, Spratt DE, Jackson WC, Feng FY, et al
Natural History of Progression After Biochemical Failure Following Postoperative Radiation Therapy in Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

SHAVERDIAN N, Demanes J, Veruttipong D, Wang J, et al
Exploring Value From the Patient's Perspective Between Stereotactic Body Radiation Therapy, Intensity Modulated Radiation Therapy, and High-Dose-Rate Brachytherapy for Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

ALEXIDIS P, Christodouleas JP, Bekelman JE, Vapiwala N, et al
The Use of High- and Very-High-Dose Radiation in the Postoperative Treatment of Prostate Cancer in the United States Between 2003 and 2012.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

WELLER MA, Kittel J, Reddy CA, Klein EA, et al
Long-Term Toxicity Comparison Between Brachytherapy and Radical Prostatectomy in High-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

HEGDE JV, Wang J, Margolis D, Huang J, et al
Establishing Predictors of Satellite Lesions in Men With Intermediate- and High-Risk Prostate Cancer for Improved Patient Selection for Focal and Focused Therapy.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

STISH BJ, Pisansky TM, Harmsen WS, Davis BJ, et al
Early Salvage Radiation Therapy Is Associated With Improved Metastasis-Free, Prostate Cancer-Specific and Overall Survival in Men With Detectable PSA Following Radical Prostatectomy.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

STOCK RG, Sfakianos J, Oh W, Stone NN, et al
Prostate-Specific Antigen Doubling Time Posttreatment Is the Most Significant Predictor of Survival Following the Brachytherapy Management of Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

SCHILD M, Wong WW, Schild SE, Vora S, et al
A Prospective Trial of Intensity Modulated Radiation Therapy Incorporating a 111-Indium-Capromab Pendetide Guided Boost for Prostate Cancer: Ten-Year Outcomes.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

SINHA S, Muralidhar V, Nguyen PL
Characteristics and National Trends of Patients Receiving Prostate or Pelvic Radiation for Metastatic Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

MALOUFF T, Marsh S, Walters RW, Silberstein P, et al
Trends in the Use of Radiation Therapy for Stage IIA Prostate Cancer From 2004 to 2013: A Retrospective Analysis Using the National Cancer Data Base (NCDB).
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

FREDMAN ET, Tabayoyong W, Ponsky L, Abouassaly R, et al
Stereotactic Body Radiation Therapy for Low-Intermediate Risk Prostate Cancer-A Single-Institution Initial Analysis of Toxicity.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

BECK R, Green WR, Kim S, Motwani SB, et al
Geography and Insurance Status: Underestimated Factors Influencing Treatment Decisions in Intermediate- and High-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

MOGHANAKI D, Harris E, Urdaneta AI, Williams M, et al
Multiparametric Magnetic Resonance Imaging Guided Salvage Low-Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer-A 15-Year Experience.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

BROWN AM, Sankineni S, Cieciera M, Mertan FV, et al
Semiautomated Prostate Cancer Segmentation on High b-Value Diffusion-Weighted Magnetic Resonance Imaging Predicts Whole Mount Histopathology.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

WANG C, Iwamoto K, Wang J, Low D, et al
Trends in Radiation-Induced Second Malignancy With Increased Utilization of Intensity Modulated Radiation Therapy for Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

KISHAN AU, Wang J, Rwigema JC, Saigal C, et al
Discord Among Radiation Oncologists and Urologists in the Postoperative Management of High-Risk Prostate Cancer: Results of an International Patterns of Care Survey.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

RAZIEE H, Murgic J, Pintilie M, Chung P, et al
Assessment of Biochemical Outcomes with Increasing Dose Escalation in Localized Prostate Cancer (PCa) Treated with Precision Image Guided Radiation Therapy (IGRT).
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

QI X, Wang J, Gomez CL, Xu X, et al
Patient-Reported Outcome After Prostate Stereotactic Body Radiation Therapy-An Analysis of Dosimetric Correlation of Minimally Import Difference for the Expanded Prostate Cancer Index Composite Short Form (EIPIC-26).
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

DESS RT, Jackson WC, Hamstra DA, Suy S, et al
Prospective Patient-Reported Outcomes After Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer: Longitudinal Predictors of Potency Preservation.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

SANFORD NN, Chen MH, Loffredo M, Renshaw A, et al
Duration of the Anti-Androgen in Men Undergoing 6 Months of an LHRH Agonist and Radiation Therapy for Unfavorable-Risk Prostate Cancer and the Risk of Death.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

SPRATT DE, Osborne J, Zumsteg ZS, Rebiez K, et al
Radium-223 Outcomes After Multiple Lines of Metastatic Castration-Resistant Prostate Cancer Therapy in Clinical Practice: Implication of Pretreatment Spinal Epidural Disease.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

OLARTE A, Gomez-Iturriaga A, Fernandez I, Casquero F, et al
Salvage Treatment in Patients With Prostate Cancer Oligorecurrence: Impact of 18-F-Fluorocholine Positron Emission Tomography/Computed Tomography on Clinical Decision Making.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

CHINEA FM, Patel V, Lamichhane N, Kwon D, et al
Exploring Heterogeneity Within Hispanic/Latino Men Diagnosed With Prostate Cancer to Identify at-Risk US Populations.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

MOON DH, Basak RS, Chen RC
Patterns of Care of Node-Positive Prostate Cancer Patients Across the United States.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

ZUMSTEG ZS, Spratt DE, Pei X, Zhang Z, et al
Redefining Unfavorable Risk Prostate Cancer: A Novel Risk Stratification Paradigm for Enhanced Outcome Prediction Via Harmonization and Unification of Risk Stratification Criteria.
Int J Radiat Oncol Biol Phys. 2016;96.
PubMed Text format

September 2016

PISANSKY TM, Agrawal S, Hamstra DA, Koontz BF, et al
Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational Study.
Int J Radiat Oncol Biol Phys. 2016 Sep 3. pii: S0360-3016(16)33158.
PubMed Text format Abstract available

August 2016

Erratum to: Nguyen PL. Rethinking the Balance of Risk and Benefit of Androgen Deprivation Therapy for Intermediate-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys 2016;94:975-977.
Int J Radiat Oncol Biol Phys. 2016;95:1549.
PubMed Text format

July 2016

ZIETMAN AL, Smith J, Klein E, Droller M, et al
Editorial Statement on Gleason Scoring for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;95:1092.
PubMed Text format

KOTECHA R, Djemil T, Tendulkar RD, Reddy CA, et al
Dose-Escalated Stereotactic Body Radiation Therapy for Patients With Intermediate- and High-Risk Prostate Cancer: Initial Dosimetry Analysis and Patient Outcomes.
Int J Radiat Oncol Biol Phys. 2016;95:960-4.
PubMed Text format Abstract available

June 2016

MULDERMANS JL, Romak LB, Kwon ED, Park SS, et al
Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;95:696-702.
PubMed Text format Abstract available

May 2016

ZILLI T, Benz E, Dipasquale G, Rouzaud M, et al
Reirradiation of Prostate Cancer Local Failures After Previous Curative Radiation Therapy: Long-Term Outcome and Tolerance.
Int J Radiat Oncol Biol Phys. 2016 May 28. pii: S0360-3016(16)30280.
PubMed Text format Abstract available

MURALIDHAR V, Rose BS, Chen YW, Nezolosky MD, et al
Association Between Travel Distance and Choice of Treatment for Prostate Cancer: Does Geography Reduce Patient Choice?
Int J Radiat Oncol Biol Phys. 2016 May 27. pii: S0360-3016(16)30278.
PubMed Text format Abstract available

DELL'OGLIO P, Boehm K, Trudeau V, Tian Z, et al
Survival After Conservative Management Versus External Beam Radiation Therapy in Elderly Patients With Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016 May 10. pii: S0360-3016(16)30196.
PubMed Text format Abstract available

HABL G, Uhl M, Katayama S, Kessel KA, et al
Acute Toxicity and Quality of Life in Patients With Prostate Cancer Treated With Protons or Carbon Ions in a Prospective Randomized Phase II Study-The IPI Trial.
Int J Radiat Oncol Biol Phys. 2016;95:435-43.
PubMed Text format Abstract available

BRYANT C, Smith TL, Henderson RH, Hoppe BS, et al
Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;95:422-34.
PubMed Text format Abstract available

UNDERWOOD T, Giantsoudi D, Moteabbed M, Zietman A, et al
Can We Advance Proton Therapy for Prostate? Considering Alternative Beam Angles and Relative Biological Effectiveness Variations When Comparing Against Intensity Modulated Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2016;95:454-64.
PubMed Text format Abstract available

ARIMURA T, Ogino T, Yoshiura T, Toi Y, et al
Effect of Film Dressing on Acute Radiation Dermatitis Secondary to Proton Beam Therapy.
Int J Radiat Oncol Biol Phys. 2016;95:472-6.
PubMed Text format Abstract available

GAMEIRO SR, Malamas AS, Bernstein MB, Tsang KY, et al
Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing.
Int J Radiat Oncol Biol Phys. 2016;95:120-30.
PubMed Text format Abstract available

April 2016

GIBSON E, Bauman GS, Romagnoli C, Cool DW, et al
Toward Prostate Cancer Contouring Guidelines on Magnetic Resonance Imaging: Dominant Lesion Gross and Clinical Target Volume Coverage Via Accurate Histology Fusion.
Int J Radiat Oncol Biol Phys. 2016 Apr 21. pii: S0360-3016(16)30121.
PubMed Text format Abstract available

MUSUNURU HB, Davidson M, Cheung P, Vesprini D, et al
Predictive Parameters of Symptomatic Hematochezia Following 5-Fraction Gantry-Based SABR in Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;94:1043-51.
PubMed Text format Abstract available

KEALL PJ, Ng JA, Juneja P, O'Brien RT, et al
Real-Time 3D Image Guidance Using a Standard LINAC: Measured Motion, Accuracy, and Precision of the First Prospective Clinical Trial of Kilovoltage Intrafraction Monitoring-Guided Gating for Prostate Cancer Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2016;94:1015-21.
PubMed Text format Abstract available

NGUYEN PL
Rethinking the Balance of Risk and Benefit of Androgen Deprivation Therapy for Intermediate-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;94:975-7.
PubMed Text format

March 2016

CHEN YW, Mahal BA, Muralidhar V, Nezolosky M, et al
Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;94:683-90.
PubMed Text format Abstract available

NGUYEN PL, Ciezki JP
High-Dose-Rate Monotherapy for Localized Prostate Cancer-What More Will It Take to Make This a Standard Therapy?
Int J Radiat Oncol Biol Phys. 2016;94:655-6.
PubMed Text format

LEWIS SL, Patel PR, Palta M, Yoo DS, et al
In Reply to Fiorino and Cozzarini.
Int J Radiat Oncol Biol Phys. 2016;94:860-1.
PubMed Text format

FIORINO C, Cozzarini C
In Regard to Lewis et al.
Int J Radiat Oncol Biol Phys. 2016;94:859-60.
PubMed Text format

NABAVIZADEH N, Elliott DA, Chen Y, Kusano AS, et al
Image Guided Radiation Therapy (IGRT) Practice Patterns and IGRT's Impact on Workflow and Treatment Planning: Results From a National Survey of American Society for Radiation Oncology Members.
Int J Radiat Oncol Biol Phys. 2016;94:850-7.
PubMed Text format Abstract available

HUYNH MA, Chen MH, Wu J, Braccioforte MH, et al
Influence of Comorbidity on the Risk of Mortality in Men With Unfavorable-Risk Prostate Cancer Undergoing High-Dose Radiation Therapy Alone.
Int J Radiat Oncol Biol Phys. 2016 Mar 11. pii: S0360-3016(16)00295.
PubMed Text format Abstract available

SLAGSVOLD JE, Viset T, Wibe A, Kaasa S, et al
Radiation Therapy Did Not Induce Long-Term Changes in Rectal Mucosa: Results From the Randomized Scandinavian Prostate Cancer Group-7 Trial.
Int J Radiat Oncol Biol Phys. 2016 Mar 3. pii: S0360-3016(16)00221.
PubMed Text format Abstract available

LEWIS SL, Patel P, Song H, Freedland SJ, et al
Image Guided Hypofractionated Postprostatectomy Intensity Modulated Radiation Therapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;94:605-11.
PubMed Text format Abstract available

February 2016

MOLINA S, Guerif S, Garcia A, Debiais C, et al
DNA-PKcs Expression Is a Predictor of Biochemical Recurrence After Permanent Iodine 125 Interstitial Brachytherapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016 Feb 11. pii: S0360-3016(16)00129.
PubMed Text format Abstract available

BOSSART EL, Stoyanova R, Sandler K, Studenski M, et al
Feasibility and Initial Dosimetric Findings for a Randomized Trial Using Dose-Painted Multiparametric Magnetic Resonance Imaging-Defined Targets in Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016 Feb 4. pii: S0360-3016(16)00105.
PubMed Text format Abstract available

FOLEY KA, Feldman-Stewart D, Groome PA, Brundage MD, et al
What Aspects of Personal Care Are Most Important to Patients Undergoing Radiation Therapy for Prostate Cancer?
Int J Radiat Oncol Biol Phys. 2016;94:280-8.
PubMed Text format Abstract available

KOUNTOURI M, Zilli T, Rouzaud M, Dubouloz A, et al
Moderate Hypofractionated Protracted Radiation Therapy and Dose Escalation for Prostate Cancer: Do Dose and Overall Treatment Time Matter?
Int J Radiat Oncol Biol Phys. 2016;94:272-9.
PubMed Text format Abstract available

MULLER AC, Eckert F, Paulsen F, Zips D, et al
Nodal Clearance Rate and Long-Term Efficacy of Individualized Sentinel Node-Based Pelvic Intensity Modulated Radiation Therapy for High-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016;94:263-71.
PubMed Text format Abstract available

NARANG AK, Gergis C, Robertson SP, He P, et al
Very High-Risk Localized Prostate Cancer: Outcomes Following Definitive Radiation.
Int J Radiat Oncol Biol Phys. 2016;94:254-62.
PubMed Text format Abstract available

January 2016

WORTEL RC, Incrocci L, Pos FJ, van der Heide UA, et al
Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From 2 Prospective Cohorts.
Int J Radiat Oncol Biol Phys. 2016 Jan 22. pii: S0360-3016(16)00052.
PubMed Text format Abstract available

ALASHKHAM A, Paterson C, Rauchhaus P, Nabi G, et al
Can Angiotensin-Converting Enzyme Inhibitors Reduce the Incidence, Severity, and Duration of Radiation Proctitis?
Int J Radiat Oncol Biol Phys. 2016;94:93-101.
PubMed Text format Abstract available

December 2015

MOTEABBED M, Trofimov A, Sharp GC, Wang Y, et al
A Prospective Comparison of the Effects of Interfractional Variations on Proton Therapy and Intensity Modulated Radiation Therapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2015 Dec 29. pii: S0360-3016(15)27220.
PubMed Text format Abstract available

HOLTZMAN AL, Hoppe BS, Letter HP, Bryant C, et al
Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or High-Intensity Focused Ultrasound.
Int J Radiat Oncol Biol Phys. 2015 Dec 19. pii: S0360-3016(15)27189.
PubMed Text format Abstract available

ROACH M 3RD, Ceron Lizarraga TL, Lazar AA
Radical Prostatectomy Versus Radiation and Androgen Deprivation Therapy for Clinically Localized Prostate Cancer: How Good Is the Evidence?
Int J Radiat Oncol Biol Phys. 2015;93:1064-1070.
PubMed Text format Abstract available

AMINI A, Jones BL, Yeh N, Rusthoven CG, et al
Survival Outcomes of Whole-Pelvic Versus Prostate-Only Radiation Therapy for High-Risk Prostate Cancer Patients With Use of the National Cancer Data Base.
Int J Radiat Oncol Biol Phys. 2015;93:1052-1063.
PubMed Text format Abstract available

BAUMAN G, Rodrigues G, Chen J, Loblaw A, et al
In Reply to Kishan et al.
Int J Radiat Oncol Biol Phys. 2015;93:1163.
PubMed Text format

KISHAN AU, Steinberg ML, Kupelian PA, King CR, et al
In Regard to Bauman et al.
Int J Radiat Oncol Biol Phys. 2015;93:1162-3.
PubMed Text format

DOWLING JA, Sun J, Pichler P, Rivest-Henault D, et al
Automatic Substitute Computed Tomography Generation and Contouring for Magnetic Resonance Imaging (MRI)-Alone External Beam Radiation Therapy From Standard MRI Sequences.
Int J Radiat Oncol Biol Phys. 2015;93:1144-53.
PubMed Text format Abstract available

TRADA Y, Kneebone A, Paneghel A, Pearse M, et al
Optimizing Radiation Therapy Quality Assurance in Clinical Trials: A TROG 08.03 RAVES Substudy.
Int J Radiat Oncol Biol Phys. 2015;93:1045-51.
PubMed Text format Abstract available

November 2015

MARIADOS N, Hamstra DA
In Reply to King et al.
Int J Radiat Oncol Biol Phys. 2015;93:937-9.
PubMed Text format

KING CR, Kamrava M, Wang PC, Steinberg ML, et al
In Regard to Mariados et al.
Int J Radiat Oncol Biol Phys. 2015;93:936-7.
PubMed Text format

MCDONALD R, Probyn L, Poon I, Erler D, et al
Tumor Response After Stereotactic Body Radiation Therapy to Nonspine Bone Metastases: An Evaluation of Response Criteria.
Int J Radiat Oncol Biol Phys. 2015;93:879-81.
PubMed Text format Abstract available

YAMOAH K, Showalter TN, Ohri N
Radiation Therapy Intensification for Solid Tumors: A Systematic Review of Randomized Trials.
Int J Radiat Oncol Biol Phys. 2015;93:737-45.
PubMed Text format Abstract available

JAWAD MS, Dilworth JT, Gustafson GS, Ye H, et al
Outcomes Associated With 3 Treatment Schedules of High-Dose-Rate Brachytherapy Monotherapy for Favorable-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2015 Nov 10. pii: S0360-3016(15)26576.
PubMed Text format Abstract available

BHATTACHARYYA T, Purushothaman K, Puthiyottil SS, Muttath G, et al
External Beam Radiation Therapy and Abiraterone in Men With Localized Prostate Cancer: Safety and Effect on Tissue Androgens. In Regard to Cho et al.
Int J Radiat Oncol Biol Phys. 2015;93:719.
PubMed Text format

CHO E, Mostaghel EA, Russell KJ, Liao JJ, et al
In Reply to Bhattacharyya et al.
Int J Radiat Oncol Biol Phys. 2015;93:719-20.
PubMed Text format

WOODRUFF HC, Fuangrod T, Van Uytven E, McCurdy BM, et al
First Experience With Real-Time EPID-Based Delivery Verification During IMRT and VMAT Sessions.
Int J Radiat Oncol Biol Phys. 2015;93:516-22.
PubMed Text format Abstract available

WESTHOFF PG, de Graeff A, Monninkhof EM, Pomp J, et al
Quality of Life in Relation to Pain Response to Radiation Therapy for Painful Bone Metastases.
Int J Radiat Oncol Biol Phys. 2015;93:694-701.
PubMed Text format Abstract available

October 2015

KUANG Y, Wu L, Hirata E, Miyazaki K, et al
In Reply to von Eyben et al.
Int J Radiat Oncol Biol Phys. 2015;93:467-8.
PubMed Text format

VON EYBEN FE, Kiljunen T, Kangasmaki A, Kairemo K, et al
Volumetric Modulated Arc Therapy Planning For Primary Prostate Cancer With Selective Intraprostatic Boost Determined By (18) f-Choline PET-CT: In Regard to Kuang et al.
Int J Radiat Oncol Biol Phys. 2015;93:466-7.
PubMed Text format

ALAM A, Mukhopadhyay ND, Ning Y, Reshko LB, et al
A Preliminary Study on Racial Differences in HMOX1, NFE2L2, and TGFbeta1 Gene Polymorphisms and Radiation-Induced Late Normal Tissue Toxicity.
Int J Radiat Oncol Biol Phys. 2015;93:436-43.
PubMed Text format Abstract available

September 2015

BLANCHARD P, Faivre L, Lesaunier F, Salem N, et al
Outcome According to Elective Pelvic Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: A Secondary Analysis of the GETUG 12 Phase 3 Randomized Trial.
Int J Radiat Oncol Biol Phys. 2015 Sep 25. pii: S0360-3016(15)26476.
PubMed Text format Abstract available

August 2015

GRANT SR, Walker GV, Koshy M, Shaitelman SF, et al
Impact of Insurance Status on Radiation Treatment Modality Selection Among Potential Candidates for Prostate, Breast, or Gynecologic Brachytherapy.
Int J Radiat Oncol Biol Phys. 2015 Aug 28. pii: S0360-3016(15)03193.
PubMed Text format Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: